Clinical trial
Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic…
NCT00126308 · Kirby Institute, Other · Terminated
Key facts
| NCT number | NCT00126308 |
|---|---|
| Title | Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy |
| Official title | A Multi-Centre, Open-Label, Randomised Study to Assess the Efficacy, Durability and Safety of Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy (FLASH) |
| Lead sponsor | Kirby Institute, Other |
| Collaborators | The University of New South Wales Abbott Industry Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline Merck Sharp & Dohme LLC Hoffmann-La Roche AIDS Council of New South Wales |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV-Associated Lipodystrophy, HIV Infections |
| Intervention type | Device |
| Interventions | poly-L-lactic acid |
| Enrollment | 100 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Aug 3, 2005 |
| Last update posted | Apr 2, 2009 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: